221 related articles for article (PubMed ID: 20941621)
1. Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview.
Salatino M; Rabinovich GA
Methods Mol Biol; 2011; 677():355-74. PubMed ID: 20941621
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.
Laderach DJ; Compagno D; Toscano MA; Croci DO; Dergan-Dylon S; Salatino M; Rabinovich GA
IUBMB Life; 2010 Jan; 62(1):1-13. PubMed ID: 20014236
[TBL] [Abstract][Full Text] [Related]
3. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
[TBL] [Abstract][Full Text] [Related]
4. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
5. Manipulating cell surface glycoproteins by targeting N-glycan-galectin interactions.
Grigorian A; Demetriou M
Methods Enzymol; 2010; 480():245-66. PubMed ID: 20816213
[TBL] [Abstract][Full Text] [Related]
6. [How do protein-glycan interactions regulate T-cell physiology?].
Toscano MA; Ilarregui JM; Bianco GA; Rubinstein N; Rabinovich GA
Medicina (B Aires); 2006; 66(4):357-62. PubMed ID: 16977975
[TBL] [Abstract][Full Text] [Related]
7. Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments.
Rabinovich GA; Ilarregui JM
Immunol Rev; 2009 Jul; 230(1):144-59. PubMed ID: 19594634
[TBL] [Abstract][Full Text] [Related]
8. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
[TBL] [Abstract][Full Text] [Related]
9. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs).
Sato S; St-Pierre C; Bhaumik P; Nieminen J
Immunol Rev; 2009 Jul; 230(1):172-87. PubMed ID: 19594636
[TBL] [Abstract][Full Text] [Related]
10. Galectins and microenvironmental niches during hematopoiesis.
Rabinovich GA; Vidal M
Curr Opin Hematol; 2011 Nov; 18(6):443-51. PubMed ID: 21912250
[TBL] [Abstract][Full Text] [Related]
11. Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet.
Hockl PF; Wolosiuk A; Pérez-Sáez JM; Bordoni AV; Croci DO; Toum-Terrones Y; Soler-Illia GJ; Rabinovich GA
Pharmacol Res; 2016 Jul; 109():45-54. PubMed ID: 26855319
[TBL] [Abstract][Full Text] [Related]
12. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?
Toscano MA; Ilarregui JM; Bianco GA; Campagna L; Croci DO; Salatino M; Rabinovich GA
Cytokine Growth Factor Rev; 2007; 18(1-2):57-71. PubMed ID: 17321195
[TBL] [Abstract][Full Text] [Related]
14. Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment.
Elola MT; Ferragut F; Méndez-Huergo SP; Croci DO; Bracalente C; Rabinovich GA
Cell Immunol; 2018 Nov; 333():34-45. PubMed ID: 29602445
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling.
Willhauck-Fleckenstein M; Moehler TM; Merling A; Pusunc S; Goldschmidt H; Schwartz-Albiez R
Angiogenesis; 2010 Mar; 13(1):25-42. PubMed ID: 20162350
[TBL] [Abstract][Full Text] [Related]
16. Cell surface glycan-lectin interactions in tumor metastasis.
Rambaruth ND; Dwek MV
Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
[TBL] [Abstract][Full Text] [Related]
17. Protein-glycan interactions in the control of innate and adaptive immune responses.
van Kooyk Y; Rabinovich GA
Nat Immunol; 2008 Jun; 9(6):593-601. PubMed ID: 18490910
[TBL] [Abstract][Full Text] [Related]
18. Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Compagno D; Gentilini LD; Jaworski FM; Pérez IG; Contrufo G; Laderach DJ
Glycobiology; 2014 Oct; 24(10):899-906. PubMed ID: 24939371
[TBL] [Abstract][Full Text] [Related]
19. The emerging functionality of endogenous lectins: A primer to the concept and a case study on galectins including medical implications.
Gabius HJ; Wu AM
Chang Gung Med J; 2006; 29(1):37-62. PubMed ID: 16642727
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment.
Croci DO; Cerliani JP; Pinto NA; Morosi LG; Rabinovich GA
Glycobiology; 2014 Dec; 24(12):1283-90. PubMed ID: 25117007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
